1. Home
  2. UTHR vs RL Comparison

UTHR vs RL Comparison

Compare UTHR & RL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • RL
  • Stock Information
  • Founded
  • UTHR 1996
  • RL 1967
  • Country
  • UTHR United States
  • RL United States
  • Employees
  • UTHR N/A
  • RL N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • RL Apparel
  • Sector
  • UTHR Health Care
  • RL Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • RL Nasdaq
  • Market Cap
  • UTHR 14.4B
  • RL 13.1B
  • IPO Year
  • UTHR 1999
  • RL 1997
  • Fundamental
  • Price
  • UTHR $308.00
  • RL $251.38
  • Analyst Decision
  • UTHR Buy
  • RL Strong Buy
  • Analyst Count
  • UTHR 12
  • RL 13
  • Target Price
  • UTHR $392.00
  • RL $288.58
  • AVG Volume (30 Days)
  • UTHR 439.7K
  • RL 838.8K
  • Earning Date
  • UTHR 04-30-2025
  • RL 05-22-2025
  • Dividend Yield
  • UTHR N/A
  • RL 1.31%
  • EPS Growth
  • UTHR 18.86
  • RL 24.59
  • EPS
  • UTHR 25.10
  • RL 10.92
  • Revenue
  • UTHR $2,994,100,000.00
  • RL $6,949,600,000.00
  • Revenue This Year
  • UTHR $11.45
  • RL $9.12
  • Revenue Next Year
  • UTHR $6.11
  • RL $3.92
  • P/E Ratio
  • UTHR $12.27
  • RL $23.02
  • Revenue Growth
  • UTHR 19.84
  • RL 5.23
  • 52 Week Low
  • UTHR $260.41
  • RL $155.96
  • 52 Week High
  • UTHR $417.82
  • RL $289.33
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 57.25
  • RL 70.46
  • Support Level
  • UTHR $290.02
  • RL $214.23
  • Resistance Level
  • UTHR $319.40
  • RL $240.39
  • Average True Range (ATR)
  • UTHR 10.02
  • RL 7.30
  • MACD
  • UTHR 2.72
  • RL 4.59
  • Stochastic Oscillator
  • UTHR 69.99
  • RL 91.88

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About RL Ralph Lauren Corporation

Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.

Share on Social Networks: